Sarcomas originating in the larynx are extremely rare and form less than 1 % of all malignant laryngeal tumors. In the past, fibrosarcoma was considered as the most common malignant mesenchymal neoplasm in the larynx and it was generally held that at least half laryngeal sarcomas were fibrosar-comas. Such imprecise statements have been included in the majority of books published on otolaryngology and surgical pathology. Many spindle-cell lesions such as fibro-matosis, nodular fasciitis, malignant fibrous histiocytoma, leiomyosarcoma, monophasic synovial sarcoma, rhabdomyosarcoma, malignant peripheral nerve sheath tumor, spindle-cell squamous carcinoma, spindle-cell melanoma, reparative lesions and inflammatory lesions were formerly indiscriminately classified as fibrosarcomas.
Fibrosarcoma has the following histologi-cal features: it has an overall, highly cellular, spindlecell pattern in a 'herringbone' arrangement; it stains positive for collagen and negative for muscle; it is intracytoplasmi-cally periodic-acid-Schiff-negative; reticulin preparation usually reveals a dense mesh-work of collagen fibers between individual cell elements; immunohistochemical investigation demonstrates vimentin reactivity but lysozyme, S-100 protein, Leu-7, neuron-specific enolase, cytokeratin, epithelial membrane antigen and myoglobin are lacking; the ultrastructural cell composition is fibroblas-tic [6] . Considering the uncertainty as to the true nature of cases reported as fibrosarco-mas, it is currently difficult to assess the behavior of this neoplasm in the larynx. Fibrosarcoma has to be differentiated from laryngeal fibromatosis which may recur but does not metastasize [7] . Accurate histo-logical diagnosis is essential in fibrosarcoma because of the differences it involves in treatment and prognosis by comparison with other tumors. Primary and recurrent tumors call for complete wide local excision, with a generous border of normal tissue. Neck dissection is not necessary for fibrosarcoma unless there is clinical evidence of metastases.
In conclusion, we must learn to distinguish a malignant tumor accurately before considering treatment.
